BPA Call 36E79724A0034-36C24526N0789
Award Date 7/31/26
Potential Completion Date 8/3/26
Potential Value $21K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
Not listed Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Carrollton, TX 75010, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $15,090.62 delivery order to Janssen Biotech, Inc. for BALVERSA 4 MG. The contract was issued against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with a firm fixed price and no set-aside designation. Janssen Biotech will provide the BALVERSA medication to the VA network in Carrollton, Texas to support healthcare services for veterans in the region. This...
- Janssen Biotech, Inc. was awarded a $15,754 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order is for BALVERSA 4MG and has a period of performance through October 17, 2022. No set-aside provisions were applied to this award issued under GSA Schedule contract FSS-61-IB. The delivery order will provide BALVERSA, a prescription oncology...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $17,046 delivery order to Janssen Biotech, Inc. under the company's Pharmaceuticals and Drugs GSA Schedule contract. The order is for BALVERSA 4MG and will be fulfilled from July 18-20, 2023 with performance taking place in Carrollton, Texas. Janssen Biotech will provide the specified oncology drug to VA-VHA under a firm fixed price arrangement. As one of the largest health care...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $15,090.62 delivery order to Janssen Biotech, Inc. for BALVERSA 4MG. The contract was issued against the Pharmaceuticals and Drugs Federal Supply Schedule, a multiple award schedule managed by the General Services Administration. Performance will take place in Frisco, Texas. No set aside designation was used for this firm fixed price order, which is scheduled for completion by...
- The Department of Veterans Affairs, through Veterans Integrated Service Network 5, awarded a $20,295.20 firm fixed-price delivery order to Janssen Biotech Inc. (doing business as Centocor Ortho Biotech Inc.) for BALVERSA 4 MG, a specialized oncology medication used in cancer treatment. This delivery order was issued on March 20, 2026, with an ultimate completion date of March 24, 2026, and will be performed in Carrollton, Texas. The award carries no set-aside designation, reflecting Janssen...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded a $11,317.97 delivery order to Janssen Biotech, Inc. for BALVERSA medication. The contract was issued against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with a firm fixed price and performance period through December 31, 2021. No set-aside designation was applied. Janssen Biotech, Inc. will provide BALVERSA medication to support healthcare services for...
- Janssen Biotech, Inc. was awarded a $15,754.46 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) master contract vehicle by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order is for the drug BALVERSA 4MG and has a period of performance through December 7, 2022. No set-aside provisions were applied to this award to supply prescription medications in support of healthcare...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $17,046 firm fixed price delivery order against GSA Schedule Pharmaceuticals and Drugs (FSS-61-IB) to Janssen Biotech, Inc. to provide BALVERSA 4MG. The place of performance is Carrollton, Texas. The period of performance is September 13-14, 2023. This delivery order supports the VA's mission to provide healthcare services to veterans through its Veterans Integrated Service Network...
- Janssen Biotech, Inc. was awarded a $17,046.33 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order is for BALVERSA 4MG and has a period of performance through June 9, 2023. No set-aside provisions were applied to this award placed under GSA Schedule contract FSS-61-IB. The delivery order will provide needed pharmaceutical supplies to...
- This is a firm fixed price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc. The order is valued at $18,125.50 and provides the VA's Veterans Health Administration (VHA) with the oncology medication BALVERSA (erdafitinib) to support healthcare services for veterans. The delivery order is placed against Janssen Biotech's existing $3.1 billion Federal Supply Schedule (FSS) contract for Pharmaceuticals and...